A Study to Evaluate AEVI-007 in Participants With Adult Onset Still's Disease

Status:
Recruiting

Trial end date:
2022-03-30

Target enrollment:

Participant gender:

The main purpose of the study is to evaluate the safety and tolerability of AEVI-007 in participants with Adult Onset Still's Disease (AOSD).

Phase 1

Cerecor Inc